ClinicalTrials.Veeva

Menu

Feasibility of a Water-soluble Contrast Application Into Dysphagia Evaluation

U

Ulsan University Hospital

Status

Completed

Conditions

Dysphagia
Swallowing Disorder

Study type

Observational

Funder types

Other

Identifiers

NCT03598491
chhwang10

Details and patient eligibility

About

In traditional video-fluoroscopic-swallowing study, a lipid-soluble contrast (barium sulfate) has been used more than 30 years. However, it can cause chemical pneumonitis and subsequently impair reliability of video-fluoroscopic-swallowing study if aspirated. The authors reviewed the safety and usefulness of an water soluble agent-based swallowing test.

Full description

Parallel-group, case-controlled trial was conducted from September 2015 to November 2017. All the patients who referred for video-fluoroscopic-swallowing study were screened.

Based on the pre-emptive evaluation, high-risky patients were allocated to iohexol (Omnipaque)-used video-fluoroscopic-swallowing study and others were allocated to barium sulfate-used video-fluoroscopic-swallowing study.

Statistical Package for the Social Sciences 24 was used to perform statistical analysis for the data. Quantitative data were presented as mean ± standard errors.

Enrollment

755 patients

Sex

All

Ages

3+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All the patients who referred for video-fluoroscopic-swallowing study

Exclusion criteria

  • none

Trial design

755 participants in 2 patient groups

Iohexol
Description:
Iohexol was applied in video-fluoroscopic-swallowing study
Barium
Description:
Barium was applied in video-fluoroscopic-swallowing study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems